Drug Shortage Report for MIDAZOLAM INJECTION

Last updated on 2022-06-01 History
Report ID 159557
Drug Identification Number 02242905
Brand name MIDAZOLAM INJECTION
Common or Proper name Midazolam Injection
Company Name FRESENIUS KABI CANADA LTD
Market Status MARKETED
Active Ingredient(s) MIDAZOLAM
Strength(s) 5MG
Dosage form(s) LIQUID
Route of administration INTRAVENOUS INTRAMUSCULAR INTRAVENOUS INTRAMUSCULAR
Packaging size 2mL
ATC code N05CD
ATC description HYPNOTICS AND SEDATIVES
Reason for shortage Disruption of the manufacture of the drug.
Anticipated start date
Actual start date 2022-05-01
Estimated end date 2022-06-03
Actual end date 2022-03-31
Shortage status Avoided shortage
Updated date 2022-06-01
Company comments Fresenius Kabi Canada regrets to advise that due to production delays, we will be experiencing supply interruptions. During our supply interruption on Midazolam Injection 5 mg/mL MD Vial 2 mL, our Midazolam Injection 5 mg/mL MD Vial 10 mL will be available for substitution.
Health Canada comments
Tier 3 Status No
Contact Address 165 GALAXY BLVD, SUITE 100
TORONTO, ONTARIO
CANADA M9W 0C8
Company contact information

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v9 2022-06-01 French Compare
v8 2022-06-01 English Compare
v7 2022-06-01 English Compare
v6 2022-05-02 English Compare
v5 2022-04-28 French Compare
v4 2022-04-28 English Compare
v3 2022-04-28 English Compare
v2 2022-04-28 French Compare
v1 2022-04-28 English Compare

Showing 1 to 9 of 9